Modulation of multidrug resistance (MDR) in hematological malignancies.
about
Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivoCircumvention of ara-C resistance by aphidicolin in blast cells from patients with AMLReversal of multidrug resistance by 5,5'-dimethoxylariciresinol-4-O-β-D-glucoside in doxorubicin-resistant human leukemia K562/DOX.Receptor induction and targeted drug delivery: a new antileukaemia strategy.Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsMechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma.Comparison of two in vitro dendritic cell maturation models for screening contact sensitizers using a panel of methacrylates.Epstein-Barr virus infection, drug resistance and prognosis in Korean T- and NK-cell lymphomas.
P2860
Q24670297-8C226101-C16A-4294-BC4E-00FE8F0C0795Q28359564-276D15C5-970C-4F89-8388-C4AA83FAF44EQ35069074-1E3C3B58-A977-489F-800C-BDC0D926AF35Q35164785-A37883EE-742B-4B28-96F8-2C4228244691Q40328451-FB976BCC-1025-43DB-B621-07979E63C897Q41770950-E3301AB7-03E8-4FAC-A27C-EFB257E6B21AQ42455062-1DF156A9-E09F-4A49-A804-4B6455807707Q45736771-7FC397F1-0D36-4496-BD0A-11E483B59BA6
P2860
Modulation of multidrug resistance (MDR) in hematological malignancies.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Modulation of multidrug resistance (MDR) in hematological malignancies.
@ast
Modulation of multidrug resistance (MDR) in hematological malignancies.
@en
type
label
Modulation of multidrug resistance (MDR) in hematological malignancies.
@ast
Modulation of multidrug resistance (MDR) in hematological malignancies.
@en
prefLabel
Modulation of multidrug resistance (MDR) in hematological malignancies.
@ast
Modulation of multidrug resistance (MDR) in hematological malignancies.
@en
P356
P1433
P1476
Modulation of multidrug resistance (MDR) in hematological malignancies.
@en
P2093
P356
10.1023/A:1008332318884
P478
10 Suppl 6
P577
1999-01-01T00:00:00Z